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Abstract
Accumulating evidence indicates that saturated fat intake is related to mortality risk increase, whereas unsaturated fat intake is associated with
reduced mortality risk. The aim of the present study was to estimate the mortality risk reduction related to a dietary change from saturated fat
to mono- or polyunsaturated fat intake. The American National Health and Nutrition Examination Surveys conducted between 1999 and
2010 were linked to the 2011 national US death registry resulting in an observational prospective mortality study. Proportional hazards
Cox models were used to evaluate the association between saturated, monounsaturated and polyunsaturated fat with all-cause and cause-specific
mortality. Substitution analysis was conducted to estimate an iso-energetic substitution of 10% of the energy from dietary fat intake applied to the
substitution of saturated fat with an equal amount of energy from monounsaturated or polyunsaturated fat. The highest tertile intakes of saturated
fat resulted in an increased risk (12%) of all-cause and specific-cause mortality, whereas the highest tertile intakes of polyunsaturated fat resulted in
a reduced risk (7%) of all-cause and specific-cause mortality when compared with the corresponding lowest tertile. Iso-energetic substitution
revealed that a substitution of 10% of energy (from total fat) from saturated fat to an equal amount of energy from monounsaturated or
polyunsaturated fat resulted in a significant reduction of the mortality risk ranging from 4 to 8%. Iso-energetic substitution of saturated fat with
monounsaturated and polyunsaturated fat reduced all-cause and specific-cause mortality in US adults.
Key words: All-cause mortality: Specific mortality: Dietary fats: Substitution analyses
CVD and cancer represent major causes of mortality in high-
income countries(1). In the USA, it was estimated that CVD and
cancer combined account for more than 50% of the overall
mortality burden among adults and represent the first and second
cause of mortality, respectively(2). It is widely acknowledged that,
among others, unhealthy diet and poor lifestyle represent major
preventable risk factors for all-cause and cardiovascular mortality
in the USA, with unhealthy diet and intake of specific dietary fat
in particular, representing a considerable part of the risk(3).
Notably, in 2010 it was estimated that saturated and trans-
unsaturated fat consumption was higher in the USA (11·8 and
2·8% of the overall energy intake, respectively) when compared
with global consumption (9·4 and 1·4% of the overall energy
intake, respectively). On the other hand, consumption of poly-
unsaturated fat consumption was comparable between the USA
and all of the other countries combined, representing about 5·9%
of the overall energy intake(4).
Population-based studies showed that high intake of poly-
unsaturated fat is associated with reduced cardiovascular risk
and related mortality(5,6). In contrast, the relationship between
saturated fat intake and CVD incidence and mortality remains
a controversial topic. Previous systematic reviews and meta-
analyses reported no significant association between saturated
fat intake and increased risk of CVD or mortality(7–9). Recent
evidence from large prospective US cohorts, however, con-
sistently showed that replacement of dietary saturated fat with
monounsaturated and polyunsaturated fat is associated with a
lower risk of CVD, as well as all-cause and cause-specific
mortality(10,11). In contrast, when replacing dietary saturated fat
with refined carbohydrates, saturated fat intake was not asso-
ciated with CVD incidence, which highlights the importance of
studying this relationship in the context of the replacement
macronutrient(10). Moreover, scientific evidence showing the
relation between dietary fat intake and cancer risk is currently
Abbreviation: NHANES, National Health and Nutrition Examination Survey.
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accumulating. In a recent meta-analysis of observational
studies, significantly increased risk of gastric cancer was asso-
ciated with higher dietary intakes of saturated fat, whereas
a reduced risk of gastric cancer was observed for those subjects
having a higher intake of unsaturated fat(12).
It is admissible to suppose that adopting a healthy diet
followed by increased consumption of mono- and poly-
unsaturated fat or the replacement of saturated fat with unsa-
turated fat may lead to beneficial outcomes in terms of overall,
cardiovascular and cancer mortality at the population level.
Recently, US guidelines recommended reducing saturated fat
intake to <10% of the total energy intake. On the other side, no
recommendation to improve mono- and polyunsaturated fat
intake was stated(13).
The aim of the present study was to estimate the association
between an increase in mono- and polyunsaturated fat intake
or the substitution of saturated fat to mono- and poly-
unsaturated fat and mortality reduction in US adults. For this
purpose, an energy partition model and an iso-energetic
substitution analysis were conducted over a prospective study
resulting from the American National Health and Nutrition




The NHANES is an epidemiological cross-sectional study aimed
to generate a representative sample of the civilian non-
institutionalised US adults using a multi-stage probability
sampling design(14). The NHANES study started in 1999 and every
year about 5000 US citizens are involved providing data regarding
their socio-economical characteristics, dietary habits, medical
status and medical history. On a regular basis, the NHANES
participants are linked to the US death registry using a probabi-
listic record linkage defining a prospective mortality study. The
last linkage to the US mortality registry was in 2011(15).
The number of all participants from the survey conducted
between 1999 and 2011 was 62 210, of whom 21 290 were
excluded because of no available data on mortality or age
under 18 years, leaving 40 870 participants. After exclusion of
subjects aged between 18 and 30 years, 30 509 subjects were
retained. Exclusion of prevalent cases of cancer, diabetes and
CVD reduced the sample to 21 344 participants. Finally, the
exclusion of subjects with missing information on fat intake and
adjusting covariates used in the models led to a final sample
size of 18 372 individuals, resulting in a cumulative observa-
tional time of 116 398 person-years with a median observational
time of 6·1 years. During the follow-up, 1118 deaths for all
causes, 267 deaths for cardiovascular cause and 289 deaths due
to cancer were observed. The flow chart of participant selection
was reported on Fig. 1.
Dietary assessment
A dietary interview assessing detailed dietary intake information
was performed to estimate types and amounts of foods and
beverages consumed and to calculate total energy intake. The
dietary interview was composed of three sections – 24-h dietary
recall, evaluation of nutritional supplements and dietary post
recall – and was administered to all NHANES participants. To
allow for better estimates of usual nutrient intakes, 2 d of dietary
data were collected for the survey performed after 2002. The
dietary post recall was conducted by telephone interview after
approximately 3–10 d from the first dietary evaluation(16).
Statistical analysis
The description of the sample was performed separately for
subjects who died during the observational time and for those
subjects who survived up to the end of the observational time.
Medians and interquartile ranges were reported for continuous
variables and percentages were reported for categorical
variables (Table 1).
All analyses were based on multivariable adjusted Cox pro-
portional hazard model having age as an underlying time
variable and stratified by sex and 5-year age classes. Raw and
multivariable adjusted models considering potential con-
founders were evaluated in a sequential modelling approach
aimed to evaluate the residual confounding bias (results not
shown). After the evaluation of the results from sequential
modelling, a multivariate model adjusted for ethnicity (Black,
White and others), BMI (continuous), alcohol intake (con-
tinuous), smoking status (more than 100 cigarettes/life), educa-
tion (university degree), sedentariness (subjects who declared
having more than 8 h/d of sedentary activity or who do not
declared moderate or vigorous physical activity), dietary fibre
intake (continuous) and blood pressure (systolic and diastolic
blood pressure as continuous data) was chosen to report
all of the results. The proportional hazard assumption was
evaluated by Schoenfeld’s residuals. Sensitivity analyses were
conducted excluding death cases assessed in the first 18 months
after recruitment. Results from the analyses evaluating the
association between tertiles of energy density of saturated,
monounsaturated and polyunsaturated fat with all-cause and
specific-cause mortality were reported along with trend tests
performed considering 1 SD increase (Table 2). The associations
between changes of fat intake and all-cause and specific-cause
mortality were performed considering the energy partition and
nutrient density paradigms as previously described by Hu
et al.(17). In brief, in the energy partition model, the total energy
from the nutrients is partitioned in the different components
contributing to the energy intake, so that nutrients are coded in
a metric of their energy contribution. In this model, the relative
risk estimate corresponds to a given increase of energy from
that specific component when all of the other components
remain constant. The analyses based on the energy partition
models were performed considering all of the dietary compo-
nents (carbohydrates, proteins and fat) and the fat components
only. On the other hand, the nutrient density model is a sub-
stitution model in which the ratio between the energy from the
single dietary component and the overall energy from all
dietary components are considered in the model so that the
sum of all the components remains constant and corresponds
to a given numerical value (100% if the percentage is used).
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This model is performed considering the energy from fat
components contributing to energy intake excluding one, so
that the relative risk estimate for a given component represents
the substitution of a given quantity (1% when the percentage is
used) of the excluded component with this one. In the present
work, the substitution model was performed considering a 10%
substitution of the energy from fat consumption only. The
reported risk then was related to 10% substitution of fat only
derived energy, excluding carbohydrates and proteins. Energy
partition and substitution analysis were reported in Table 3.
All statistical analyses were performed taking into account the
multi-stage probability sampling design of the NHANES study
using the weights from the multi-stage probability sampling to
avoid the effect of differential probabilities of selection among
subgroups, and to compensate for exclusion of sampling areas
in the sampling frame. The surveymean and the surveyfreq
procedures of the SAS software were used to describe the
sample, whereas the Cox models were fitted using the proc
surveyphreg of the SAS software. Statistical analyses were
performed using SAS package version 9.4 and type-I error (α)
was set to 0·05 (5%).
Results
Participants who survived at the end of the observational time
were younger, mostly women, prevalently non-smokers, with
lower systolic blood pressure and had higher intake of dietary
fibre and overall energy when compared with participants who
had died before the end of the observational time. Adiposity in
terms of BMI and percentages of energy from fat, carbohydrates
and protein intakes were comparable among those participants
who survived at the end of the observational time and those
who died. The analysis of the relation between fat intake and
all-cause and specific-cause mortality showed that higher
intakes of saturated fat resulted in an increased risk of mortality,
whereas higher intakes of polyunsaturated fat resulted in a
decreased risk of mortality. In particular, comparing the first
tertile (7·1%) with the third tertile (14·5%) of energy percentage
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Fig. 1. Flow chart of participants selected from National Health and Nutrition Examination Survey (NHANES) surveys conducted between 1999 and 2010. * Subjects
without mortality data or aged under 18 years old. † Subjects having at least one of the following: congestive heart failure, CHD, angina pectoris, heart attack and stroke.
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from saturated fat resulted in a significant 12% increased risk for
all-cause, cardiovascular and cancer mortality (hazard ratio
(HR) 1·12; 95% CI 1·07, 1·18; HR 1·12; 95% CI 1·06, 1·17 and HR
1·12; 95% CI 1·06, 1·17 for all-cause and cancer mortality,
respectively). On the other hand, when comparing the first
tertile (4·4%) with the third tertile (10·2%) of energy percentage
from polyunsaturated fat, a significant reduction of all causes
and specific cause risk of death up to 7% was observed (HR
0·94; 95% CI 0·90, 0·98; HR 0·93; 95% CI 0·89, 0·97 and HR 0·93;
95% CI 0·89, 0·97 for all-cause, cardiovascular and cancer
mortality, respectively). Notably, the association between
monounsaturated fat intake and mortality was not significant.
Partition models reported about the associations between a
given increase in fat intake and mortality risk when maintaining
constant the other sources of energy. According to these ana-
lyses, it was observed that an increase of 418·4 kJ/d (100 kcal/d)
in any of the fats did not correspond to a significant change of
the mortality risk when energy intake from other fats, carbo-
hydrates and proteins remained constant. On the contrary,
when the analysis is performed maintaining constant the energy
from fat sources only, a 418·4 kJ/d (100 kcal/d) increase in
saturated fat intake resulted in a 9% significantly increased risk
for all-cause, cardiovascular and cancer mortality. On the other
hand, a 418·4 kJ/d (100 kcal/d) increase in polyunsaturated fat
intake corresponded to a 2–3% significant reduction in risk for
all-cause and cardiovascular mortality when energy intake from
other fat remains constant. Again, monounsaturated fat intake
was not significantly related to the risk of death.
The iso-energetic substitution analysis applied to energy
intake from fat only revealed that the substitution of 10% of
energy derived from saturated fat with an equal amount of
energy from polyunsaturated fat resulted in an 8% significant
reduction in all-cause mortality risks. Substitution of saturated
fat with monounsaturated fat resulted in a 3% borderline
significant risk reduction for all-cause mortality. A 4% decreased
risk in all-cause mortality was observed in the substitution model
considering the substitution of 10% of energy (from fat) derived
from saturated fat with an equal amount of energy from mono-
unsaturated fat. Finally, an iso-energetic substitution of 10% of
energy derived from monounsaturated fat with an equal amount
of energy from polyunsaturated fat resulted in a significant
decrease in all-cause and specific-cause mortality by 4 to 5%.
Results considering all-cause mortality were confirmed also for
cause-specific mortality where 8% cardiovascular and cancer
death risk reduction was reported for the substitution of saturated
fat with an equal amount of polyunsaturated fat. An evocative,
but not statistically significant (P= 0·0621 and P= 0·0548 for
cardiovascular and cancer death risk, respectively), 3% cardio-
vascular and cancer death risk reduction was reported for
the substitution of 10% of energy from saturated fat with an
equal amount of monounsaturated fat. The above results are
maintained when excluding subjects who died in the first
18 months after recruitment (results not shown).
Discussion
In this observational prospective mortality study in US adults,
higher saturated fat intake was associated with increased risk
for all-cause mortality, CVD and cancer mortality. On the other
hand, a reduction of all-cause and specific-cause mortality risk
was observed for those participants having a higher intake of
polyunsaturated fat compared with those having lower intakes
Table 1. Baseline characteristics of the 18 372 participants from the National Health and Nutrition Examination Survey study
(Medians and 1st, 3rd quartiles; percentages)
Alive at the end of the







Median 1st, 3rd quartile Median 1st, 3rd quartile Median 1st, 3rd quartile Median 1st, 3rd quartile
Age (years) 45·0 37·2, 54·3 65·5 51·0, 78·0 70·5 54·7, 79·5 59·7 48·4, 72·2
Sex (% of men) 47·9 44·1 53·6 61·6
Ethnicity (%)
Black 19·4 19·9 20·6 24·2
White 49·1 58·1 57·3 50·5
Others 31·5 21·9 22·1 25·3
University degree (%) 22·9 11·1 12·7 10·4
BMI (kg/m2) 27·4 24·1, 31·6 26·7 23·3, 31·0 26·1 22·2, 30·9 27·7 25·1, 31·5
Smoking status≥100 cigarettes/life (%) 37·4 41·9 42·0 46·3
Alcohol use among users (g/d) 20·7 7·7, 40·5 22·6 11·2, 48·3 21·6 8·8, 22·9 25·9 12·7, 58·1
Non-users (%) 67·4 73·1 76·4 72·0
Sedentary (%) 76·7 84·6 84·8 81·7
SBP (mmHg) 119·2 110·0, 130·3 132·9 119·3, 149·6 136·6 123·5, 153·8 131·5 117·5, 143·7
DBP (mmHg) 72·8 65·6, 79·7 70·9 62·7, 79·5 68·9 61·9, 79·6 72·7 65·8, 80·5
Dietary fibres (g/d) 15·0 10·4, 21·0 12·9 8·8, 18·0 13·1 9·3, 18·5 12·6 8·5, 17·4
Energy (kJ/d) 8590 6468, 11230 7565 5531, 10004 7619 5623, 9715 7577 5531, 9866
SFA (% of energy) 10·9 8·7, 13·1 10·7 8·5, 13·2 10·6 8·3, 12·4 10·8 8·6, 13·2
MFA (% of energy) 12·2 10·1, 14·4 12·0 9·5, 14·5 11·8 9·3, 14·1 12·2 9·8, 14·6
PFA (% of energy) 6·8 5·3, 8·8 6·2 4·8, 8·2 6·1 4·3, 8·6 6·0 4·9, 8·1
All fat (% of energy) 35·7 32·1, 39·6 36·0 29·6, 38·1 33·6 29·6, 38·1 35·3 30·8, 39·7
Carbohydrates (% of energy) 49·0 42·1, 55·6 48·8 41·9, 55·4 51·6 44·4, 58·7 49·5 38·8, 57·1
Proteins (% of energy) 15·3 12·9, 18·2 15·2 12·8, 18·1 14·8 12·6, 18·3 15·2 12·4, 18·4
SBP, systolic blood pressure; DBP, diastolic blood pressure; MFA, monounsaturated fat; PFA, polyunsaturated fat.
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of polyunsaturated fat. The present study confirmed evidence
from randomised control trials on the beneficial effect of
polyunsaturated fat intake on cardiovascular function(18). In
addition, the present work reported about the beneficial
outcomes deriving from mono- and polyunsaturated fat
substituting saturated fat in terms of mortality at a population
level. In summary, the present findings point out a beneficial
association between a diet rich in monounsaturated and
specifically polyunsaturated fat and low in saturated fat; these
findings are confirmed by previous studies(5,18,19). Notably, the
present study extended this evidence to cancer mortality to
a complementary extent.
In the present study, a significant relation between
monounsaturated fat intake and mortality risk was not found
differently from previous studies(11). On the other hand, the
present study showed that a substitution of 10% of energy from
saturated fat with an equal amount of energy from mono-
unsaturated fat resulted in a borderline reduction of mortality
risk. This result points out the suggestive idea that substitution
of saturated fat with monounsaturated fat, more than an
increase of monounsaturated fat intake per se, might be asso-
ciated with a beneficial outcome in terms of mortality risk(20).
According to our results regarding partition models, an increase
of unsaturated fat and a decrease of saturated fat intake have
beneficial effects only when maintaining constant the energy
from other fat sources excluding carbohydrates and proteins.
The finding from the present study implies that substitution of
saturated fat with polyunsaturated fat is possibly related to
even stronger beneficial association with the mortality out-
comes that were investigated. As a confirmation of the previous
conjecture in the present study, the iso-energetic substitution of
saturated fat with unsaturated fat was associated with a
significantly reduced risk for all-cause and cause-specific
mortality. This evidence was suggested indirectly from
previous studies evaluating the relation between fat intake and
cardiovascular and overall mortality(18,21). Again, for the first
time to our knowledge the present work extends the evidence
of a beneficial effect of the substitution of saturated fat intake
with mono- and polyunsaturated fat on cancer mortality. This
further emphasises the importance of the type of dietary fat in
Table 2. Associations between tertiles of total energy percentage from intake of specific fat and all-cause, cardiovascular and cancer mortality
(Hazard ratios (HR) and 95% confidence intervals)
1st tertile (7·1%) 2nd tertile (10·5%) 3rd tertile (14·5%)
Saturated dietary fats HR 95% CI HR 95% CI HR 95% CI
Deaths (n 1118) 392 336 390
All-cause mortality* 1 Ref. 1·09 1·04, 1·13 1·12 1·07, 1·18
1 SD increase* 1·05 1·02, 1·07 Ptrend≤ 0·0001
CVD deaths (n 267) 99 87 81
CVD mortality* 1 Ref. 1·08 1·03, 1·12 1·12 1·06, 1·17
1 SD increase* 1·04 1·02, 1·06 Ptrend= 0·0002
Cancer deaths (n 289) 96 93 100
Cancer mortality* 1 Ref. 1·08 1·03, 1·13 1·12 1·06, 1·17
1 SD increase* 1·04 1·02, 1·06 Ptrend= 0·0002
Person-years (116 398) 39 513 38187 38 698
Monounsaturated dietary fat 1st tertile (8·4%) 2nd tertile (12·0%) 3rd tertile (15·9%)
Deaths (n 1118) 402 328 388
All-cause mortality* 1 Ref. 1·00 0·96, 1·05 0·98 0·93, 1·03
1 SD increase* 1·01 0·98, 1·03 Ptrend= 0·6610
CVD deaths (n 267) 103 80 84
CVD mortality* 1 Ref. 1·00 0·96, 1·04 0·99 0·94, 1·04
1 SD increase* 1·01 0·99, 1·03 Ptrend= 0·3652
Cancer deaths (n 289) 97 88 104
Cancer mortality* 1 Ref. 1·00 0·95, 1·04 0·98 0·93, 1·03
1 SD increase* 1·01 0·99, 1·03 Ptrend= 0·4644
Person-years (116 398) 38 343 38002 40 053
Polyunsaturated dietary fat 1st tertile (4·4%) 2nd tertile (6·7%) 3rd tertile (10·2%)
Deaths (n 1118) 449 350 319
All-cause mortality* 1 Ref. 1·02 0·98, 1·06 0·94 0·90, 0·98
1 SD increase* 0·98 0·96, 0·99 Ptrend= 0·0127
CVD deaths (n 267) 113 81 73
CVD mortality* 1 Ref. 1·01 0·97, 1·05 0·93 0·89, 0·97
1 SD increase* 0·97 0·95, 0·99 Ptrend= 0·0018
Cancer deaths (n 289) 122 87 80
Cancer mortality* 1 Ref. 1·01 0·97, 1·05 0·93 0·89, 0·97
1 SD increase* 0·97 0·96, 0·99 Ptrend= 0·0026
Person-years (116 398) 40 957 37359 38 082
Ref., referent values.
* Models are adjusted for ethnicity, BMI, alcohol intake, smoking status, education, sedentariness, fibre intake and blood pressure.
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all-cause and cause-specific mortality. Results from the present
study are comparable with those from other studies in which
substitution analysis was used to evaluate mortality risk reduc-
tion in the USA. In particular, the present study confirms
previous findings regarding fat substitution analysis performed
in the Nurses’ Health Study where it appeared that saturated to
polyunsaturated fat substitution in diet reduces mortality(11). In
the present study, it was also confirmed that saturated to poly-
unsaturated fat substitution and not saturated fat substitution
with other sources of energy, such as carbohydrates, effectively
results in beneficial outcomes in terms of mortality. Finally, it
must be noticed that no relevant differences in terms of adipo-
sity were observed when looking at survivors and participants
who experience death before the end of the observational time.
On the other hand, it should be noticed that survivors were
younger, healthier and mostly women, whereas participants
who died were older, prevalently smokers and prevalently men.
This apparently affected adiposity reducing the mean of the
BMI in non-survivors. Scientific evidence accumulated over the
past decades already explained the possible mechanisms
underlying the association between dietary fat intake and
cardiovascular outcomes. An early identified mechanism is
the mediation between plasma cholesterol level and dietary
saturated fat intake. A recent meta-analysis conducted in
humans and considering the association between dietary
saturated fat intake with main cardiovascular outcomes and
mortality reinforced this evidence by means of meta-regressions
and subgroup analysis(19). Among the other factors related
to the relation between saturated fat and cardiovascular
outcomes, adiposity certainly plays a crucial role(22). Obesity and
overweight are conditions normally correlated to high energy
intake and sedentariness. Obese and overweight subjects nor-
mally also have suboptimal diet and high intakes of saturated
fat(23,24). Nevertheless, obesity and overweight were associated
with circulating cytokines and other inflammatory biomarkers
that are related to atherosclerosis and then to main cardiovas-
cular outcomes(25). Moreover, obesity and overweight were
consistently associated with increased risk of different cancers
through mechanisms acting by impaired hormonal status and
increased type 2 diabetes risk(26–28). It is then admissible to
suppose that unhealthy diet and a related high saturated fat
intake may play a role in leading to an increased cardiovascular
and all-cause mortality risk via adiposity-related mechanisms.
Mechanisms about how saturated fat intake may result in an
increased cardiovascular risk were widely reported in scientific
literature. In particular, saturated fat increases the HDL
cholesterol and reduces LDL particles heterogeneity in size
increasing their density(29). It was shown that smaller and
denser LDL particles are strongly associated with athero-
sclerosis, CVD and stroke(30,31).
Biological mechanisms regarding polyunsaturated dietary fat
intake in relation to cardiovascular outcomes and adiposity have
been proposed. A general beneficial effect of polyunsaturated
dietary fat on cardiovascular function may be related to its activity
in depressing plasma lipids, inhibition of apo synthesis and inhi-
bition of cyclo-oxygenases and lipoxygenases activity, which, in
turn, reduces eicosanoid synthesis decreasing thromboxane and
platelets tendency to aggregate(32). On the other hand, there is
some evidence suggesting that polyunsaturated dietary fats are
beneficial in terms of preventing obesity, overweight and type 2
Table 3. Partition and substitution models for the association between dietary fat intake and all-cause, cardiovascular and
cancer mortality
(Hazard ratios (HR) and 95% confidence intervals)
Saturated fat Monounsaturated fat Polyunsaturated fat
Model* HR 95% CI HR 95% CI HR 95% CI
Partition model1
All-cause mortality 1·02 0·99, 1·04 1·00 0·97, 1·03 1·01 0·98, 1·04
CVD mortality 1·01 0·98, 1·04 1·01 0·98, 1·04 1·00 0·97, 1·03
Cancer mortality 1·01 0·98, 1·04 1·00 0·97, 1·03 1·00 0·98, 1·03
Partition model2
All-cause mortality 1·09 1·06, 1·12 1·01 0·98, 1·04 0·98 0·96, 1·00
CVD mortality 1·09 1·06, 1·12 1·02 0·99, 1·05 0·97 0·94, 0·99
Cancer mortality 1·09 1·06, 1·12 1·02 0·99, 1·05 1·00 0·98, 1·03
Substitution model1
All-cause mortality – 0·97 0·93, 1·00 0·92 0·90, 0·95
CVD mortality – 0·97 0·93, 1·01 0·92 0·90, 0·95
Cancer mortality – 0·97 0·94, 1·01 0·92 0·90, 0·95
Substitution model2
All-cause mortality 1·04 1·00, 1·08 – 0·96 0·92, 1·00
CVD mortality 1·03 0·99, 1·07 – 0·95 0·91, 0·99
Cancer mortality 1·03 0·99, 1·07 – 0·95 0·91, 0·99
Substitution model3
All-cause mortality 1·08 1·05, 1·11 1·04 1·00, 1·09 –
CVD mortality 1·08 1·06, 1·11 1·05 1·01, 1·10 –
Cancer mortality 1·08 1·06, 1·11 1·05 1·01, 1·09 –
* Partition model1: energy partition model considering dietary fat, carbohydrates and proteins, risks for 418·4 kJ (100 kcal) increase of dietary fat
maintaining constant all of the other components. Partition model2: energy partition model considering only dietary fat, risks for 418·4 kJ (100 kcal)
increase of dietary fat maintaining constant all of the other components. Substitution model1: substitution of 10% of energy from total fat intake derived
from saturated fat. Substitution model2: substitution of 10% of energy from total fat intake derived from monounsaturated fat. Substitution model3:
substitution of 10% of energy from total fat intake derived from dietary polyunsaturated fat.
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diabetes risk(33). Finally, polyunsaturated fat intake may result as
beneficial in terms of all-cause and cancer-related mortality also
because of their antioxidative activity(34,35).
The present work has limitations owing to its observational
nature that limit the proposed results in terms of causal asso-
ciation. On one hand, it is acknowledged that randomised con-
trolled trials and meta-analysis of interventional studies were
conducted to evaluate such diet interventions and the effect of fat
components on biomarkers of short-term outcomes(36). On the
other hand, it is clear that these approaches cannot be technically
performed when long-term outcomes, such as mortality, are
considered in healthy subjects. Moreover, in the past, rando-
mised control trials resulted in inconsistent outcomes as obser-
vational time, more than the sample size, is an operational
limit(19). Nevertheless, another possible limitation was that the
saturated and polyunsaturated type was not taken into account.
This information represents an interesting public health question
and will be certainly considered by further studies. Finally,
underlying morbid conditions at baseline could have affected the
results without any possibility of control. This second limitation
and a related possible reversal causation can be excluded as
prevalent morbid conditions at baseline were excluded in the
main analysis and death in the first 18 months from follow-up
was excluded in a sensitivity analysis.
Conclusions
High intake of saturated fat corresponded to an increased risk
of mortality in US adults, high intake of polyunsaturated fat resulted
in a reduced mortality risk in US adults and high intake of
monounsaturated fat did not reduce mortality risk in US adults.
Substitution of saturated fat with monounsaturated and poly-
unsaturated fat led to beneficial mortality reduction at the popu-
lation level, highlighting the importance of the type of fat in the diet.
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